JPMorgan thinks may take time for market to digest Halozyme bid for Evotec
After Halozyme Therapeutics (HALO) confirmed it has submitted a non-binding proposal to the boards of Evotec (EVO) to acquire Evotec for EUR ...
Europe midday: Pharma stocks slide on Kennedy pick as US health chief
European equity markets trimmed losses on Friday with pharma stocks lower on news that Robert F. Kennedy Jr – who has made ...
The Globe and Mail16m
Stocks Tumble as Hawkish Fed and Strong US Economic News Boosts Bond Yields
Halozyme Therapeutics (HALO) is down more than -11% after Bloomberg News reported the company submitted a $2.1 billion bid to acquire Evotec SE. Advanced Auto Parts (AAP) is down more than -8% after ...
Hosted on MSN2m
European shares end lower on US rate, Trump jitters
Evotec jumped 21% after Halozyme Therapeutics said it has proposed to buy the German drug developer for about 2 billion euros ...
Piper Sandler Sticks to Its Hold Rating for Halozyme (HALO)
Piper Sandler analyst Joseph Catanzaro maintained a Hold rating on Halozyme (HALO – Research Report) today and set a price target of ...